Cargando…
Decreased BRCA1 Confers Tamoxifen Resistance in Breast Cancer Cells by Altering Estrogen Receptor-Coregulator Interactions
The breast cancer susceptibility gene 1 (BRCA1) is mutated in approximately 50% of hereditary breast cancers, and its expression is decreased in 30–40% of sporadic breast cancers, suggesting a general role in breast cancer development. BRCA1 physically and functionally interacts with estrogen recept...
Autores principales: | Wen, Jie, Li, Rong, Lu, Yunzhe, Shupnik, Margaret A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714665/ https://www.ncbi.nlm.nih.gov/pubmed/18997820 http://dx.doi.org/10.1038/onc.2008.405 |
Ejemplares similares
-
Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?
por: Shupnik, Margaret A
Publicado: (2007) -
Role of estrogen receptor coregulators in endocrine resistant breast cancer
por: Altwegg, Kristin A., et al.
Publicado: (2021) -
Coregulation of FANCA and BRCA1 in human cells
por: Haitjema, Anneke, et al.
Publicado: (2014) -
Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017) -
BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?
por: Wang, Li, et al.
Publicado: (2014)